Aurinia Pharmaceuticals

Quote
anonymous said:
What is the issue with sales? Price of the drug? Poor leadership? MD’s choosing Benlyata instead?
Used to be a longtime shareholder but lost faith in Greenleaf.
Click to expand...

he’s a nice enough guy as far as CEOs go, but very much a job hopper impressed with his own “intelligence” which translates to “don’t rock the boat, and don’t be left holding the bag”
 






anonymous said:
he’s a nice enough guy as far as CEOs go, but very much a job hopper impressed with his own “intelligence” which translates to “don’t rock the boat, and don’t be left holding the bag”
Click to expand...
I really liked Richard Glickman. I thought he was a man of great integrity so gave Greenleaf every opportunity to produce based on Glickman bringing him in.
If he did move on, I’d reinvest in company. Poking Sun for the Dry Eye infringement, when Aurinia stopped their dry eye program after phase 2, poked them into patent lawsuit.
Unforced error that could ruin company in a matter of a couple years.
Good luck, sales team. I always thought voclosporin would be a home run.
 






anonymous said:
I really liked Richard Glickman. I thought he was a man of great integrity so gave Greenleaf every opportunity to produce based on Glickman bringing him in.
If he did move on, I’d reinvest in company. Poking Sun for the Dry Eye infringement, when Aurinia stopped their dry eye program after phase 2, poked them into patent lawsuit.
Unforced error that could ruin company in a matter of a couple years.
Good luck, sales team. I always thought voclosporin would be a home run.
Click to expand...

I wish someone would buy us
 


















anonymous said:
They want strong rheum and/or nephr relationships. They were comfortable with $125k base. One of the big pharma companies is launching a competitor soon.
Click to expand...

whew buddy… you are selling yourself short. They are laughing at 125k. Go back and try 185-205k. No joke. It’s crappy they would divulge that to you, if you came on ar 125k you’d be the lowest paid rep that I know of!!
 












P is the luckiest man on the planet. Can you think of any other CEO that is getting paid big bucks with millions for options every year for running a company into the ground?
 


















Turn Out The Lights, The Party’s Over-

Lupkynis Faces Challenges In Lupus
Nephritis Market

Mar. 21, 2023 5:57 PM ET | Aurinia Pharmaceuticals Inc.

Summary

• Despite positive results from the AURA-LV study, Lupkynis has not become the preferred LN treatment, leading to Aurinia's missed 2022 revenue projection.

A study indirectly comparing drug regimens for LN induction therapy indicates tacrolimus plus MMF is likely the most effective, followed by Lupkynis plus MMF.

Per prominent treatment recommendations, voclosporin, the active ingredient in Lupkynis, is recommended as a viable alternative for initial LN therapy, but not as the top choice.

Although there has been a legal settlement, Aurinia's treatment protocol patent may still be subject to questioning, which could potentially enable competitors to enter the market when the exclusivity period ends in 2026, despite providing some protection against generic competition.

Aurinia's Lupkynis, SELL, SELL SELL
 






Today is National PIP day. If you haven't figured it out, Habig knows we have too many ISS. Leave, Leave, Leave, and go enjoy your summer. This has been the most under appreciated company I have ever been a part of.
 












"We believe that the Aurinia board has consistently failed to carry out its important role to supervise the company management's performance and ensure the management's adequate performance," Iljin SNT wrote in a letter to the board on Wednesday.

Management, including front line managers consistently display a shocking inability to grasp basic leadership concepts!
 






More employees are leaving each week since the announcement. Many employees still at the company are applying for jobs elsewhere. No one is truly working hard, everyone is focused on using vacation time, planning their future careers and enjoying life.
 












anonymous said:
More employees are leaving each week since the announcement. Many employees still at the company are applying for jobs elsewhere. No one is truly working hard, everyone is focused on using vacation time, planning their future careers and enjoying life.
Click to expand...
If they become a subsidiary, wouldn’t purchaser retain at least the top salespeople?
 












Does Greenleaf really think he can operate under this cloud of uncertainty (won't give updates to progress) while employees leave the company because the future is not known?....selling or not. I can't believe that this ambiguity is keeping the morale up at the company. Nearly 75 days in to this SR and nothing.
 












Top Bottom
Back
Quote